Disopyramide Phosphate Capsule, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Disopyramide Phosphate Capsule, Extended Release (capsule, extended release) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Aug 24, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0025-2742-31
- Dosage Form
- Capsule, Extended Release
- Presentation
- Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)
- Initial Posting
- Aug 24, 2026